Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5473.

https://doi.org/10.1182/blood-2023-180603

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5482.

https://doi.org/10.1182/blood-2023-180634

Published: 2023

Journal Articles

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination

Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, Simona Maria Siboni, Pier Mannuccio Mannucci, Flora Peyvandi

Blood (2022) 140 (Supplement 1): 11286–11287.

https://doi.org/10.1182/blood-2022-162183

Published: 2022

Journal Articles

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Flora Peyvandi, MD PhD, Paolo Bucciarelli, MD, Carla Valsecchi, BSc, Marco Boscarino, Roberta Palla, PhD, Elena Santagostino, Amal El-Beshlawy, Mohsen Saleh Elalfy, MD, Vijay M. Ramanan, MBBS,MDDM, Peyman Eshghi, MD, Suresh Hanagavadi, MD, Mehran Karimi, MD, Cecil Ross, MD, Mamta V Manglani, MD, Guy Young, Tulika Seth, MDMBBS,FAAP, Shashikant Apte, MD FRCPA, Dinesh M Nayak, MD, Maria Elisa Mancuso, Johnny Mahlangu, Bonanad Santiago, MD, Monica H Cerqueira, MD PhD, Nadia P Ewing, MD, Christoph Male, MD, Tarek Owaidah, MDFRCPA, Veronica Soto Arellano, MD, Suvankar Majumdar, MBCHB, Mindy Simpson, MD, Mathew Thomas, MD, Ezio Zanon, Marilyn J Manco-Johnson, MD, Monica Martinez, MD, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Rogelio Alejandro Paredes-Aguilera, MD, Alessandra N L Prezotti, MD MSc, Klaus Schmitt, MD, Bulent Zulfikar, Prof, Pier Mannuccio Mannucci, MD, Frits Richard Rosendaal, MD

Blood (2018) 132 (Supplement 1): 384.

https://doi.org/10.1182/blood-2018-99-114599

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Recombinant Von Willebrand Factor Administration: Dosing Considerations and Rapid Stabilization of Endogenous Plasma FVIII Levels in Patients with Severe Von Willebrand Disease

Joan Cox Gill, MD, Pier Mannuccio Mannucci, Margaret V. Ragni, MD MPH, Giancarlo Castaman, Flora Peyvandi, Bettina Ploder, Aaron Novack, Peter Chen, Arthur Sytkowski, Bruce Ewenstein

Blood (2017) 130 (Supplement 1): 3682.

https://doi.org/10.1182/blood.V130.Suppl_1.3682.3682

Published: 2017

Journal Articles

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Antonino Cannavò, Carla Valsecchi, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Flora Peyvandi

Blood (2017) 129 (10): 1245–1250.

https://doi.org/10.1182/blood-2016-06-720086

Published: 2017

Includes: Supplemental data

Journal Articles

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, MD PhD, Pier Mannuccio Mannucci, MD, Isabella Garagiola, PhD, Mohsen Elalfy, MD, Amal El-Beshlawy, MD, Madatha V. Ramanan, MD, Peyman Eshghi, MD, Suresh Hanagavadi, Ramabadran Varadarajan, MD, Mehran Karimi, MD, Mamta V. Manglani, MD, Cecil Ross, MD, Guy Young, MD, Tulika Seth, MD, Shashikant Apte, MD FRCPA, Dinesh M. Nayak, MD, Adriana C. Sandoval Gonzales, MD, Elena Santagostino, MD PhD, Maria Elisa Mancuso, MD PhD, Johnny N. Mahlangu, MD, Santiago Bonanad, PhD, Monica Cerqueira, MD, Nadia P. Ewing, MD, Christoph Male, MD MSC, Tarek Owaidah, MD FRCPA, Veronica Soto Arellano, MD, Nathan L. Kobrinsky, MD FRCP, Suvankar Majumdar, MD, Rosario Perez Garrido, MD, Anupam Sachdeva, Mindy Simpson, MD FAAP, Mathew Thomas, Ezio Zanon, MD, ALI Bulent Antmen, Kaan Kavakli, MD, Marilyn Manco-Johnson, MD, Monica Martinez, MD, Esperanza Marzouka, MS, PS, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Angeles Palomo Bravo, MD, Rogelio Paredes Aguilera, MD, Alessandra Nunes Loureiro Prezotti, MD, Schmitt Klaus, MD, Brian M. Wicklund, MD MPH, Bulent Zulfikar, MD, Rosendaal R. Frits, MD PhD

Blood (2015) 126 (23): 5.

https://doi.org/10.1182/blood.V126.23.5.5

Published: 2015

Journal Articles

Very Elderly Patients with Chronic Phase-Chronic Myeloid Leukemia on Imatinib: No Impact of Concomitant Drugs on Complete Cytogenetic Response

Alessandra Iurlo, MD PhD, Roberto Latagliata, MD, Cristina Bucelli, MD, Dario Ferrero, MD, Fausto Castagnetti, MDPhD, Massimo Breccia, MD, Elisabetta Abruzzese, MD, Daniele Cattaneo, MD, Carmen Fava, MD, Antonella Gozzini, MD, Mario Annunziata, MD, Mario Tiribelli, MD, Patrizia Pregno, MD, Fabio Stagno, MDPhD, Paolo Vigneri, MDPhD, Francesco Cavazzini, MD, Gianni Binotto, Giovanna Mansueto, MD, Sabina Russo, MD, Franca Falzetti, MD, Enrico Montefusco, MD, Gabriele Gugliotta, PhD, Cristiana Gasbarrino, MD, Ada D'Addosio, MD, Laura Cortesi, Michele Cedrone, MD, Antonella Russo Rossi, MD, Paolo Avanzini, MD, Mauro Endri, MD, Antonio Spadea, MD, Francesca Celesti, MD, Gianfranco Giglio, MD, Alessandro Isidori, MD PhD, Monica Crugnola, MD, Elisabetta Calistri, Federica Sorà, MD PhD, Giovanna Rege-Cambrin, MD, Simona Sica, Luigia Luciano, MD, Ester Maria Orlandi, MD, Monica Bocchia, MD, Mauro Tettamanti, Giuliana Alimena, MD, Giuseppe Saglio, MDPhD, Gianantonio Rosti, MD, Alessandro Nobili, Pier Mannuccio Mannucci, MD, Agostino Cortelezzi, MD

Blood (2015) 126 (23): 1582.

https://doi.org/10.1182/blood.V126.23.1582.1582

Published: 2015

Journal Articles

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Augusto B. Federici, Paolo Bucciarelli, Giancarlo Castaman, Maria G. Mazzucconi, Massimo Morfini, Angiola Rocino, Mario Schiavoni, Flora Peyvandi, Francesco Rodeghiero, Pier Mannuccio Mannucci

Blood (2014) 123 (26): 4037–4044.

https://doi.org/10.1182/blood-2014-02-557264

Published: 2014

Journal Articles

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, Thynn Thynn Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein

Blood (2013) 122 (5): 648–657.

https://doi.org/10.1182/blood-2013-01-479527

Published: 2013

Includes: Supplemental data

Journal Articles

ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates

Flora Peyvandi, Pier Mannuccio Mannucci, MD, Carla Valsecchi, Silvia Pontiggia, Jonathan Bernstein, MS, MD, Stefano Guazzini, PhD, Anastassios Retzios, PhD

Blood (2012) 120 (21): 3383.

https://doi.org/10.1182/blood.V120.21.3383.3383

Published: 2012

Journal Articles

How we choose factor VIII to treat hemophilia

Pier Mannuccio Mannucci, Maria Elisa Mancuso, Elena Santagostino

Blood (2012) 119 (18): 4108–4114.

https://doi.org/10.1182/blood-2012-01-394411

Published: 2012

Journal Articles

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

Ida Martinelli, Piero Ruggenenti, Irene Cetin, Giorgio Pardi, Annalisa Perna, Patrizia Vergani, Barbara Acaia, Fabio Facchinetti, Giovanni Battista La Sala, Maddalena Bozzo, Stefania Rampello, Luca Marozio, Olimpia Diadei, Giulia Gherardi, Sergio Carminati, Giuseppe Remuzzi, Pier Mannuccio Mannucci

Blood (2012) 119 (14): 3269–3275.

https://doi.org/10.1182/blood-2011-11-391383

Published: 2012

Includes: Supplemental data

Journal Articles

Getting rid of refractory hemophilia

Pier Mannuccio Mannucci

Blood (2012) 119 (6): 1326–1327.

https://doi.org/10.1182/blood-2011-12-394429

Published: 2012

Journal Articles

Source and Purity of Factor VIII Products As Risk Factors for Inhibitor Development In Previously Untreated Patients with Severe Hemophilia A

Maria Elisa Mancuso, MD, PhD, Pier Mannuccio Mannucci, MD, Angiola Rocino, MD, Isabella Garagiola, Annarita Tagliaferri, Elena Santagostino, MD, PhD

Blood (2011) 118 (21): 25.

https://doi.org/10.1182/blood.V118.21.25.25

Published: 2011

Journal Articles

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Uri Martinowitz, MD, Amy D. Shapiro, MD, Doris V. Quon, MD, PhD, Miguel Antonio Escobar, MD, Christine L Kempton, MD, MSc, Peter Collins, MD, Pratima Chowdary, MD, Michael Makris, MD, Pier Mannuccio Mannucci, MD, Massimo Morfini, MD, Leonard A. Valentino, MD, Edward D. Gomperts, MD, Martin Lee, PhD

Blood (2011) 118 (21): 2267.

https://doi.org/10.1182/blood.V118.21.2267.2267

Published: 2011

Journal Articles

JAK2 (V617F) Mutation and Cerebral Venous Thrombosis,

Ida Martinelli, MD, PhD, Serena Maria Passamonti, MD, Eugenia Biguzzi, MD, Franca Franchi, PhD, Francesca Gianniello, MD, Paolo Bucciarelli, MD, Daniela Pietra, PhD, Pier Mannuccio Mannucci, MD, Mario Cazzola

Blood (2011) 118 (21): 3339.

https://doi.org/10.1182/blood.V118.21.3339.3339

Published: 2011

Journal Articles

Identification of DEEP Vein Thrombosis GENETIC RISK Variants by NEXT GENERATION Sequencing of Hemostatic Genes

Luca Andrea Lotta, Mark Wang, Jin Yu, Fuli Yu, Ida Martinelli, Serena Passamonti, Emanuela Pappalardo, Marzia Menegatti, Lora L Lewis, Walker Hale, IV, Donna M Muzny, Pier Mannuccio Mannucci, Richard A Gibbs, Flora Peyvandi

Blood (2011) 118 (21): 710.

https://doi.org/10.1182/blood.V118.21.710.710

Published: 2011

NARROW

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Recombinant Von Willebrand Factor Administration: Dosing Considerations and Rapid Stabilization of Endogenous Plasma FVIII Levels in Patients with Severe Von Willebrand Disease

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Very Elderly Patients with Chronic Phase-Chronic Myeloid Leukemia on Imatinib: No Impact of Concomitant Drugs on Complete Cytogenetic Response

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates

How we choose factor VIII to treat hemophilia

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

Getting rid of refractory hemophilia

Source and Purity of Factor VIII Products As Risk Factors for Inhibitor Development In Previously Untreated Patients with Severe Hemophilia A

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

JAK2 (V617F) Mutation and Cerebral Venous Thrombosis,

Identification of DEEP Vein Thrombosis GENETIC RISK Variants by NEXT GENERATION Sequencing of Hemostatic Genes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only